Topical and cryoanaesthesia for livestock husbandry. The livestock industries contribute $15billion annually to Australia's economy, playing a vital role in rural communities. However we must respond to changing demands of our customers, by complementing our competitive disease-free advantage with welfare-conscious production systems. This project will address the threat of growing international demands for improved animal welfare in farming. We will provide research and technical solutions, pro ....Topical and cryoanaesthesia for livestock husbandry. The livestock industries contribute $15billion annually to Australia's economy, playing a vital role in rural communities. However we must respond to changing demands of our customers, by complementing our competitive disease-free advantage with welfare-conscious production systems. This project will address the threat of growing international demands for improved animal welfare in farming. We will provide research and technical solutions, providing pain mangement products for on-farm use that will reduce animal suffering during routine husbandry interventions. The project offers significant benefits for producers by protecting their industries against the threats of a welfare embargo on our livestock products. Read moreRead less
Liver fluke: improving disease control through understanding of parasite diversity, drug resistance and better diagnosis. The benefits from this research include: (i) development of knowledge that will allow a better use of existing drug formulations to protect livestock from fasciolosis, potentially generating economic benefits to Australian producers of up to $50-80m/year; (ii) improved application of new commercial therapies for fasciolosis in ruminants, improving producer prosperity; (iii) ....Liver fluke: improving disease control through understanding of parasite diversity, drug resistance and better diagnosis. The benefits from this research include: (i) development of knowledge that will allow a better use of existing drug formulations to protect livestock from fasciolosis, potentially generating economic benefits to Australian producers of up to $50-80m/year; (ii) improved application of new commercial therapies for fasciolosis in ruminants, improving producer prosperity; (iii) enhanced training opportunities for graduate students that will build human capacity in technologies such as molecular diagnostics which have a wide application across the animal sectors; (iv) enhancement of our capacity to respond to unexpected future threats in production animals.Read moreRead less